Lisa Marr
University of New Mexico
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Lisa Marr.
Cancer | 2008
Anthony L. Back; Wendy G. Anderson; Lynn Bunch; Lisa Marr; James A. Wallace; Holly B. Yang; Robert M. Arnold
Cancer communication near the end of life has a growing evidence base, and requires clinicians to draw on a distinct set of communication skills. Patients with advanced and incurable cancers are dealing with the emotional impact of a life‐limiting illness, treatment decisions that are complex and frequently involve consideration of clinical trials, and the challenges of sustaining hope while also having realistic goals. In this review, the authors sought to provide a guide to important evidence about communication for patients with advanced cancer regarding communication at diagnosis, discussing prognosis, decision making about palliative anticancer therapy and phase 1 trials, advance care planning, transitions in focus from anticancer to palliative care, and preparing patients and families for dying and death. Cancer 2008;113(7 suppl):1897–910.
American Journal of Public Health | 2014
Joanna G. Katzman; George D. Comerci; Michael Landen; Larry Loring; Steven M. Jenkusky; Sanjeev Arora; Summers Kalishman; Lisa Marr; Chris Camarata; Daniel Duhigg; Jennifer Dillow; Eugene Koshkin; Denise E. Taylor; Cynthia M. A. Geppert
Chronic pain and opioid addiction are 2 pressing public health problems, and prescribing clinicians often lack the skills necessary to manage these conditions. Our study sought to address the benefits of a coalition of an academic medical center pain faculty and government agencies in addressing the high unintentional overdose death rates in New Mexico. New Mexicos 2012-2013 mandated chronic pain and addiction education programs studied more than 1000 clinicians. Positive changes were noted in precourse and postcourse surveys of knowledge, self-efficacy, and attitudes. Controlled substance dispensing data from the New Mexico Board of Pharmacy also demonstrated safer prescribing. The total morphine and Valium milligram equivalents dispensed have decreased continually since 2011. There was also a concomitant decline in total drug overdose deaths.
Annals of palliative medicine | 2015
Rodrigo Rodriguez; Lisa Marr; Ashwani Rajput; Bridget N. Fahy
BACKGROUND Palliative medicine was recognized as a unique medical specialty in 2006. Since that time, the number of hospital-based palliative care services has increased dramatically. It is unclear how palliative care consultation services (PCCS) are utilized by surgical services. The purpose of this study was to examine utilization of PCCS by surgical services compared to medical services at the University of New Mexico. METHODS A database of palliative care consultations performed at University of New Mexico Hospital between 2009 and 2013 was queried to identify consultations requested by surgical vs. medical services. Demographic, clinical, and outcome variables were compared. RESULTS A total of 521 consultations were analyzed: 441 (85%) consultations from medical and 80 (15%) consultations from surgical services. Surgical patients were older than medical patients and more likely to be in an intensive care unit (ICU) at the time of consultation. There was no difference between referring services in indication for palliative care consultation or time from hospital admission to consultation. Surgical patients were more likely to die in the hospital compared to medical patients. Among patients discharged from the hospital alive, there was no difference between the groups in discharge disposition. More patients in both groups had a change from full code to do-not-resuscitate (DNR) status following palliative care consultation. CONCLUSIONS Referrals for palliative care consultations are much less common from surgical than medical services. Characteristics of surgical patients suggest that palliative care consultations are reserved for older patients, critically ill patients, and those more likely to be at end-of-life. Our findings suggest the possible need for increased palliative care consultations among less critically ill patients and/or those with an improved prospect of recovery.
American Journal of Public Health | 2016
Joanna G. Katzman; Chris Fore; Snehal R. Bhatt; Nina Greenberg; Julie Griffin Salvador; George C. Comerci; Christopher Camarata; Lisa Marr; Rebecca Monette; Sanjeev Arora; Andrea Bradford; Denise E. Taylor; Jenny Dillow; Susan V. Karol
We examined the benefits of a collaboration between the Indian Health Service and an academic medical center to address the high rates of unintentional drug overdose in American Indians/Alaska Natives. In January 2015, the Indian Health Service became the first federal agency to mandate training in pain and opioid substance use disorder for all prescribing clinicians. More than 1300 Indian Health Service clinicians were trained in 7 possible 5-hour courses specific to pain and addiction. We noted positive changes in pre- and postcourse knowledge, self-efficacy, and attitudes as well as thematic responses showing the trainings to be comprehensive, interactive, and convenient.
Journal of Palliative Medicine | 2006
Fareeha Siddiqui; Lisa Marr; David E. Weissman
NM is found at autopsy in 20% of patients with cancer. Among solid tumors, NM is common in breast cancer, small cell lung cancer, and melanoma while rare in gastrointestinal/gynecologic cancers. Ninety percent of patients with solid tumors with NM have widespread metastatic disease. NM is found in 40%–50% of patients with hematologic malignancies—mostly commonly acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and high-grade lymphomas (large cell, Burkitt’s).
Clinical Journal of The American Society of Nephrology | 2015
Sarah L. Goff; Nwamaka D. Eneanya; Rebecca G. Feinberg; Michael J. Germain; Lisa Marr; Joan Berzoff; Lewis M. Cohen; Mark Unruh
BMC Palliative Care | 2015
Nwamaka D. Eneanya; Sarah L. Goff; Talaya Martinez; Natalie Gutierrez; Jamie Klingensmith; John L. Griffith; Casey Garvey; Jenny Kitsen; Michael J. Germain; Lisa Marr; Joan Berzoff; Mark Unruh; Lewis M. Cohen
Clinical Journal of The American Society of Nephrology | 2016
Daniel Cukor; Lewis M. Cohen; Elizabeth L. Cope; Nasrollah Ghahramani; S. Susan Hedayati; Denise M. Hynes; Vallabh O. Shah; Francesca Tentori; Mark Unruh; Jeanette Bobelu; Scott D. Cohen; Laura M. Dember; Thomas Faber; Michael J. Fischer; Rani I. Gallardo; Michael J. Germain; Donica Ghahate; Nancy K. Grote; Lori M. Hartwell; Patrick J. Heagerty; Paul L. Kimmel; Nancy G. Kutner; Susan Lawson; Lisa Marr; Robert G. Nelson; Anna Porter; Phillip Sandy; Bruce Struminger; Lalita Subramanian; Steve Weisbord
Journal of Palliative Medicine | 2012
Lisa Marr; Devon Neale; Venita K. Wolfe; Judith Kitzes
The journal of supportive oncology | 2013
Kalen Fletcher; Holly G. Prigerson; Elizabeth Paulk; Jennifer S. Temel; Esme Finlay; Lisa Marr; Ruth McCorkle; Lorna Rivera; Francisco Munoz; Paul K. Maciejewski